Rocket Group

Rocket Pi, also known as Rocket School (Huzhou) Aerospace Technology Co., Ltd., is a Chinese aerospace company founded in 2020 by Cheng Wei, with Wan Mei as a co-founder. Headquartered in Beijing, the company also operates in Shanghai and has a base in Taicang, Suzhou. Rocket Pi is focused on developing launch vehicles to facilitate a commercial space biology laboratory, aiming to provide services for the biomedical industry.

The company's business model revolves around the research, development, and manufacturing of spacecraft and rockets to create accessible microgravity environments for scientific research, particularly in space pharmaceuticals and breeding. Its core products include small liquid-fueled launch vehicles, such as the self-developed "Darwin" series, and biological satellites. The firm serves research institutions and biomedical companies, having established cooperation agreements with Shanghai Jiao Tong University and Ruijin Hospital to explore the space biomedical market.

In December 2021, Rocket Pi successfully launched its first space bio-payload, "Spark-1," which carried mouse adipose-derived stem cells on a suborbital flight to verify its technology. The company is also developing the "Darwin II" rocket, a small liquid carrier rocket designed to carry payloads into low-earth orbit. Rocket Pi secured tens of millions of yuan in a pre-A financing round in June 2022, led by Huagai Capital, with funds designated for the R&D of its first satellite and rocket.

Keywords: aerospace, launch vehicles, space biology, microgravity research, biomedical industry, commercial space, liquid-fuel rockets, biological satellites, space pharmaceuticals, payload management, Cheng Wei, in-orbit experiments, Chinese aerospace, Darwin rocket, Spark payload